Dr. Percent is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22395 Edgewater Dr
Port Charlotte, FL 33980Phone+1 941-766-7222Fax+1 941-766-0970
Education & Training
- University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
- University of Alabama Medical CenterResidency, Internal Medicine, 2002 - 2005
- Louisiana State University School of Medicine in New OrleansClass of 2002
Certifications & Licensure
- FL State Medical License 2008 - 2026
- AL State Medical License 2004 - 2008
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Clinical Trials
- A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer Start of enrollment: 2015 Apr 29
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- 57 citationsSafety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.Scott S Tykodi, Lucio N Gordan, Robert S Alter, Edward Arrowsmith, Michael R Harrison
Journal for Immunotherapy of Cancer. 2022-02-01 - 142 citationsNivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.Taofeek K. Owonikoko, Keunchil Park, Ramaswamy Govindan, Neal Ready, Martin Reck
Journal of Clinical Oncology. 2021-03-08 - 26 citationsSafety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.Hamid Emamekhoo, Mark R. Olsen, Bradley Curtis Carthon, Alexandra Drakaki, Ivor John Percent
Cancer. 2021-11-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: